Overview

Observational Study in Japanese Type 2 Diabetes Patients

Status:
Completed
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
This study is designed to address the gap in the literature related to changing treatment regimen or formulation between different types of insulin, and how this change impacts quality of life, adherence, individual patient treatment satisfaction and glycemic control.
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Insulin
Insulin, Globin Zinc